American Association for Cancer Research

AACR in the News

Page:   1 2 3 4 5 6 7 8 9 10  next
Results Per Page 

American Association for Cancer Research Recognizes 2014 Research Grantees at Annual Meeting

April 16, 2014

SAN DIEGO — The American Association for Cancer Research (AACR) honored 32 new grant recipients at the AACR Annual Meeting 2014, held here,...

New Blood-based Biomarker May Predict Recurrence of Breast Cancer and Treatment Response

April 15, 2014

PHILADELPHIA — A newly developed, noninvasive blood-based assay, cMethDNA, is highly sensitive and specific in detecting breast cancer...

Elana Simon Recognized With Inaugural AACR Young Champion in Cancer Research Award

April 14, 2014

SAN DIEGO — The American Association for Cancer Research (AACR) honored Elana Simon, a survivor of fibrolamellar hepatocellular carcinoma who...

Irregular Menstruation May Predict Increased Risk of Death From Ovarian Cancer

April 9, 2014

SAN DIEGO — Women with irregular menstrual cycles had a twofold increased risk of death from ovarian cancer, according to a large, prospective...

Higher Coffee Intake May Reduce Liver Cancer Risk

April 9, 2014

SAN DIEGO — The more cups of coffee a person drank, the lower the risk for developing hepatocellular carcinoma (HCC), the most common type of...

Prediagnosis Obesity Predicts Poor Outcome for Colorectal Cancer Patients, Even Those With a Tumor Marker Linked to Better Outcomes

April 9, 2014

SAN DIEGO — High body mass index (BMI), an indicator of obesity, before a colorectal cancer diagnosis was associated with increased risk of...

American Association for Cancer Research Concludes Annual Meeting, Sets Attendance Record

April 8, 2014

SAN DIEGO — The American Association for Cancer Research (AACR) Annual Meeting 2014 in San Diego (April 5-9) set an attendance record with more...

Nearly $5 Million in Research Grants Awarded for Innovative Pancreatic Cancer Research

April 8, 2014

SAN DIEGO — The Pancreatic Cancer Action Network and the American Association for Cancer Research (AACR) awarded 14 grants through the 2014...

Study Identifies Potential New Approach to Overcome Breast Cancer Resistance to HER2-targeted Therapies

April 8, 2014

SAN DIEGO — Resistance to a combination of HER2-targeted therapies, trastuzumab and lapatinib, was associated with elevated activation of a...

Targeted Investigational Therapy Shows Early Promise Against Multiple Cancer Types

April 8, 2014

// SAN DIEGO — The investigational, oral drug BGJ398, which blocks the activity of a family of proteins called fibroblast...

New Immunotherapy IMCgp100 Shows Early Promise in Advanced Melanoma Patients

April 8, 2014

SAN DIEGO — A new type of immunotherapy that directs patients’ immune responses toward tumor cell killing, IMCgp100, was well tolerated...

Study Identifies Frequent Cause of Breast Cancer Resistance to Investigational PI3K-alpha Inhibitor

April 8, 2014

SAN DIEGO — Loss of the tumor suppressor PTEN was a frequent cause of resistance to the investigational drug BYL719, which blocks the activity...

Stand Up To Cancer and the Farrah Fawcett Foundation Announce New HPV Translational Research Team Grant

April 7, 2014

SAN DIEGO — Stand Up To Cancer (SU2C) and the Farrah Fawcett Foundation, along with the American Association for Cancer Research (AACR),...

New SU2C-Lustgarten Foundation Pancreatic Cancer Convergence Dream Team Announced

April 7, 2014

SAN DIEGO — Stand Up To Cancer (SU2C), The Lustgarten Foundation, and the Fox Family Cancer Research Funding Trust, along with the American...

Blood-based Biomarker May Identify Prostate Cancers That Will Be Resistant to Enzalutamide

April 7, 2014

SAN DIEGO — Men with metastatic, castration-resistant prostate cancer who started treatment with the drug enzalutamide (Xtandi) and had a...

American Association for Cancer Research Inaugurates New Leadership at 2014 Annual Meeting

April 7, 2014

SAN DIEGO — The American Association for Cancer Research (AACR) welcomes Carlos L. Arteaga, M.D., as president of the organization for...

Investigational Anticancer Drug May Benefit Subgroup of Patients With Head and Neck Cancer

April 7, 2014

SAN DIEGO — Patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN), the most common form of head and neck...

Request for Applications Now Open for New Stand Up To Cancer-Cancer Research UK Translational Research Fellowship

April 7, 2014

PHILADELPHIA — The American Association for Cancer Research (AACR) is now accepting applications for the Stand Up To Cancer (SU2C)-Cancer...

New Investigational Epigenetic Therapy Shows Clinical Activity Against Several Blood Cancers

April 7, 2014

SAN DIEGO — Patients with a variety of hematological, or blood, cancers benefited from treatment with OTX015, a member of a new class of...

I-SPY 2 Trial Identifies Subset of Breast Cancer Patients Most Likely to Benefit From Neratinib

April 7, 2014

SAN DIEGO — The I-SPY 2 trial identified a neo-adjuvant regimen containing the investigational drug neratinib and standard chemotherapy to be...

Page:   1 2 3 4 5 6 7 8 9 10  next
Results Per Page